LCM
XERS icon

Legato Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Legato Capital Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Buy
241,341
+7,197
+3% +$46K 0.16% 194
2026
Q1 		$1.36M Sell
234,144
-3,287
-1% -$21.8K 0.12% 223
2025
Q4 		$1.86M Buy
237,431
+20,626
+10% +$162K 0.16% 196
2025
Q3 		$1.76M Hold
216,805
– – 0.19% 157
2025
Q2 		$1.01M Sell
216,805
-513
-0.2% -$2.35K 0.12% 274
2025
Q1 		$1.19M Buy
217,318
+75,154
+53% +$303K 0.16% 206
2024
Q4 		$482K Buy
+142,164
New +$457K 0.06% 443

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legato Capital Management's XERS Position: Q2 2026 in Review

Legato Capital Management increased its Xeris Biopharma Holdings (XERS) stake by 3.1% in Q2 2026, buying an estimated $46K and bringing the position to 241,341 shares worth $1.91M. The position accounts for 0.16% of the portfolio, ranked #194.

Legato Capital Management first reported a position in XERS in Q4 2024 and has held it in 7 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Legato Capital Management held 241,341 shares of Xeris Biopharma Holdings worth $1.91M as of Q2 2026.
  • Legato Capital Management bought 7,197 Xeris Biopharma Holdings shares in Q2 2026, an estimated $46K.
  • Xeris Biopharma Holdings made up 0.16% of Legato Capital Management's portfolio in Q2 2026, its #194 holding.
  • Legato Capital Management first reported a position in Xeris Biopharma Holdings in Q4 2024 and has held it in 7 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.